
|Articles|November 1, 2002
Ablation method predictable, safe in small multicenter trial
Author(s)Lynda Charters
Nice, France-Preliminary data suggest that visual outcomes are excellent with the VISX WavePrint ablation method (VISX) for custom laser vision correction. At the European Society of Cataract and Refractive Surgery meeting, Douglas D. Koch, MD, described results of the VISX Study Group with 171 patients. He is professor of ophthalmology, The Allen, Mosbacher, and Law Chair in Ophthalmology, Cullen Eye Institute, Baylor College of Medicine, Houston.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
FDA approves carbachol–brimonidine eye drop for presbyopia following phase 3 BRIO trials
2
MacTel Decoded: Rethinking Conventional Approaches with Novel Neuroprotective Strategies
3
Study finds artificial tear viscosity and shear-thinning behavior vary by formulation
4
When Mites Meet Their Match: Empowering Patients With Targeted Treatment for Demodex Blepharitis
5



























